about
Versican degradation and vascular diseaseVersican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4Cleavage of focal adhesion kinase in vascular smooth muscle cells overexpressing membrane-type matrix metalloproteinasesA single nucleotide polymorphism in the p27(Kip1) gene is associated with primary patency of lower extremity vein bypass grafts.Inhibition of PDGF-B induction and cell growth by syndecan-1 involves the ubiquitin and SUMO-1 ligase, ToporsHeparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells.VASP phosphorylation at serine239 regulates the effects of NO on smooth muscle cell invasion and contraction of collagenBone morphogenetic protein 4: potential regulator of shear stress-induced graft neointimal atrophy.Accumulation and loss of extracellular matrix during shear stress-mediated intimal growth and regression in baboon vascular grafts.A link between smooth muscle cell death and extracellular matrix degradation during vascular atrophyScavenger receptor class A member 5 (SCARA5) and suprabasin (SBSN) are hub genes of coexpression network modules associated with peripheral vein graft patency.Platelet-derived growth factor-BB transactivates the fibroblast growth factor receptor to induce proliferation in human smooth muscle cells.Induction of vascular atrophy as a novel approach to treating restenosis. A reviewProliferative capacity of vein graft smooth muscle cells and fibroblasts in vitro correlates with graft stenosis.Cell death-associated ADAMTS4 and versican degradation in vascular tissue.Surgical marking pen dye inhibits saphenous vein cell proliferation and migration in saphenous vein graft tissueCholesterol homeostasis of skin fibroblasts after incubation with postabsorptive and postprandial lipoproteins. The effect of a fatty meal.The role of plasminogen, plasminogen activators, and matrix metalloproteinases in primate arterial smooth muscle cell migration.Membrane-type matrix metalloproteinase-1 and -3 activity in primate smooth muscle cells.Increased plasmin and serine proteinase activity during flow-induced intimal atrophy in baboon PTFE grafts.Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation.Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1.Concomitant blockade of platelet-derived growth factor receptors alpha and beta induces intimal atrophy in baboon PTFE grafts.Arterial injury repair in nonhuman primates-the role of PDGF receptor-beta.Activation of metalloproteinases and their association with integrins: an auxiliary apoptotic pathway in human endothelial cells.Smooth muscle cells of human veins show an increased response to injury at valve sites.Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery.Syndecan-4 Is Required for Thrombin-induced Migration and Proliferation in Human Vascular Smooth Muscle CellsAnti-phosphorylcholine IgM, an Anti-inflammatory Mediator, Predicts Peripheral Vein Graft Failure: A Prospective Observational StudyVersican is differentially regulated in the adventitial and medial layers of human vein graftsControl of smooth muscle cell function by membrane-type matrix metalloproteinasesGrowth factor gene expression by intimal cells in healing polytetrafluoroethylene graftsRegulation of low-density lipoprotein metabolism by cell density and proliferative stateEffects of cell density and cell proliferation on acid cholesterol esterase and cathepsin activity of cultured human skin fibroblastsThe effects of 17 beta-estradiol and progesterone on the metabolism of free fatty acid by perfused livers from normal female and ovariectomized ratsRegulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitorAlterations of plasma HDL lipids and apolipoproteins in female rats treated with ethynyl estradiolA possible role for MMP-2 and MMP-9 in the migration of primate arterial smooth muscle cells through native matrixRegulation of baboon arterial smooth muscle cell plasminogen activators by heparin and growth factorsMetabolism of low density lipoprotein by bovine endothelial cells as a function of cell density
P50
Q24600539-EF1C53D3-6531-4332-A02B-41151B040760Q28207975-94EC1460-91EA-4772-97A2-D2910D4FBE07Q28252717-CB72C61C-164C-448E-83B1-686B1F2B40BEQ30539541-ACB274BC-EFEA-436A-8463-6100704823DCQ31086903-88ECA142-0D84-4D99-8ED1-B3BAE5EBFDEBQ34143433-D98FEAA5-2A40-4A47-A9EE-328C10E87547Q34567261-264D5DEE-959C-4116-A7AA-43B23C6B76C0Q34567420-554223F7-B7EC-4DAD-A7E6-2698C42663E8Q34576649-6F6E372D-E62A-4572-BB72-3ADBB98F2102Q35085903-617287B0-C0D4-4793-AEF3-B92221DA263AQ36233760-B76EA2BA-B8C8-4779-ACFD-807BB0007243Q36357770-96F7E40B-53D8-4C2C-934C-C2F092645280Q36976632-827D2B34-1D15-42C3-9EF6-9E84DDDDCC4DQ37218194-069AF83F-9334-4733-AEF7-47528D22D40DQ37308470-B6CD717F-DA8F-4C9D-9720-F641A2867063Q41877106-A797D975-44B4-4F6E-9236-92DBAF1D98BFQ42468827-DF348712-B9F4-4A38-A934-5A73EC449663Q42526786-3D41545E-3DC0-4EEC-BCA9-4BE8F1EA445DQ43711887-A4EC6FDE-FF1D-4907-9813-41D5F6480ABFQ43909340-3F8F5E60-4E37-4207-A14E-240699D168DCQ45206419-7079C6A4-2C0A-4DF3-8855-EFD62063C377Q46256567-3207981B-EDB9-42FE-884C-775FA5FFC80DQ47242755-31B6475A-799D-43D7-948E-536A497C6956Q47653179-CA70289A-2BC1-454E-BD5B-2101086BC523Q51033758-CBDBEE5A-366E-4C3F-9F28-D6E369DC1667Q52764667-AE07A8A0-EF27-488C-88C5-2FA50FB4FA5CQ54569934-DCF55860-5CFF-4C20-985D-2240535B4926Q57372313-E152A443-C631-4CA5-8F33-697080ECABBBQ57813329-A3680485-1884-4194-91AE-6C3D9C97806BQ59126562-DFBC32ED-1593-4B9F-BB39-E64EA96A7219Q64379252-F52F7259-9492-4EBE-9EBF-9A0042763F76Q68752548-F6DBCF53-5BF6-46BC-A583-91C5DEDF3E3BQ70158871-F60D02F4-103E-4A27-9052-B8C377744609Q70178875-18B44802-C98E-416E-84EF-13C8CB03398AQ70724829-BE38CA96-AE03-4264-9437-3C941505970DQ70865447-7F31D7D5-0338-406E-ADB3-7750FE21CDA2Q71062090-1982D7EC-33B7-45B6-B276-21A48021B10FQ71659536-F3BE4ECA-9000-4867-B60E-23E088DFB6F5Q72121578-15343847-233D-4C7C-A7C1-1D74FF3332B8Q72388337-C6ED5FD4-5170-4937-8AB0-958032C01034
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-2021-5565
@en
name
Richard D Kenagy
@ast
Richard D Kenagy
@en
Richard D Kenagy
@es
Richard D Kenagy
@nl
type
label
Richard D Kenagy
@ast
Richard D Kenagy
@en
Richard D Kenagy
@es
Richard D Kenagy
@nl
prefLabel
Richard D Kenagy
@ast
Richard D Kenagy
@en
Richard D Kenagy
@es
Richard D Kenagy
@nl
P106
P1153
6701520676
P31
P496
0000-0002-2021-5565